Yan Li
Senior Director, Process Development Cabaletta Bio
Yan Li is Senior Director of Process Development at Cabaletta Bio, where she leads strategies to advance scalable cell therapy manufacturing and optimise process workflows. With extensive experience in CAR-T and advanced therapy process development, Yan has presented at major industry forums on topics including whole blood processing, comparability studies, and high-throughput manufacturing approaches. Her work focuses on enhancing manufacturing robustness and accelerating cell therapy readiness for clinical and commercial success. Yan’s insights bridge technical execution and strategic innovation in cell therapy process development.
Seminars
Thursday 16th July 2026
Advancing End-to-End Automated Manufacturing to Accelerate Autologous Cell Therapy Development Without Compromising Approval Timelines
9:00 am
- Implementing high-level automation strategies in parallel with ongoing clinical development to advance technology without impacting critical product approval timelines
- Transferring existing manual manufacturing platforms into fully automated end-to-end systems while managing comparability risks and maintaining process consistency
- Applying regulatory interaction lessons learned during automation implementation to navigate compliance requirements and avoid costly development timeline disruptions
